Öis 公開
[search 0]
もっと
Download the App!
show episodes
 
Artwork

1
Kuva ois kiva

Suomen Valokuvataiteen museo

Unsubscribe
Unsubscribe
月ごとの
 
Kuva ois kiva on Suomen Valokuvataiteen museon podcast, jossa puhutaan kuvasta. Se katsoo valokuvaa aina myös laajemmin, avaten sen yhteiskunnallisen tai historiallisen kontekstin. Jokaisessa jaksossa kuunnellaan yksi kiehtova kuva ja kuullaan suomalaisen valokuvauksen mielenkiintoisimpia ihmisiä. Kuva ois kiva on vuoden museoviestintäteko finalisti 2023. Kaikki jakson kuvat ja muita linkkejä löytyvät Valokuvataiteen museon sivulta: https://www.valokuvataiteenmuseo.fi/fi/podcast Podcastin on ...
  continue reading
 
Artwork

1
Oisko Betaa

Oisko Betaa

Unsubscribe
Unsubscribe
月ごとの
 
Tervetuloa kiipeilyn kovaan, kauniiseen, kitkalliseen ja kitkattomaan maailmaan. Me ollaan Monica ja Julia kaksi kiipeilijää, jotka etsivät vastauksia kiipeilymaailmasta ja sen ilmiöistä. Olemme kiipeilyn sanansaattajia, kysymysmestareita ja vastaus hunttereita. Ennen kaikkea haluamme kuitenkin kannustaa kaikkia elämään kiipeilyä juuri niin kuin itse haluaa. // IG: oiskobetaa. // www.oiskobetaa.fi
  continue reading
 
retour à l’école et promenade à Auvers-sur-Oise Ce matin, Lisa est retournée à l’école. Hier soir, elle a préparé son cartable.— J’ai l’impression que c’est la rentrée, m’a-t-elle dit. Je me demande comment seront les autres élèves de la classe, comment sera ma maîtresse. Et puis, tout à coup, je me dis « Ah, mais je les connais déjà ! »
  continue reading
 
Loading …
show series
 
Don't miss the latest episode of the OIS Retina Podcast, where we sit down with optometrist and ophthalmology researcher Brian Levy for an illuminating discussion on the future of eye care. In this episode, Brian takes us on a journey through his career, from his early days in vet school to his groundbreaking work at Presbyterian Medical Center, Ae…
  continue reading
 
In this latest episode of OIST’s podcast featuring researchers from the OIST Global Bioconvergence Center of Innovation, a center dedicated to promoting mental, physical, and environmental health based on the “One World, One Health” approach, OIST Podcaster in Residence, DJ Nick Luscombe spoke with Prof. Kenji Doya, leader of the Neural Computation…
  continue reading
 
Tune in to the latest episode of the Eye On Innovation podcast where Carey Powers dives into the dynamic world of biotech investor pitch decks with special guest Dr. Rob Rothman, Founding Partner of InFocus Capital Partners. Discover the top five mistakes to avoid when crafting your pitch deck and gain exclusive insights from Dr. Rothman's wealth o…
  continue reading
 
Join us this week on the OIS podcast as host Carey Powers sits down with Dr. Paul Karpecki to explore the latest advancements in presbyopia treatment strategies. Here's what you can expect from this insightful conversation: Insider Insights: Dr. Karpecki shares insider insights gleaned from his extensive clinical experience and research in the fiel…
  continue reading
 
In the latest episode of the OIS Podcast, host Dr. Robert Rothman engages in a captivating dialogue with Dr. Prasad Sunkara, CEO of Eyegenex. Key points discussed in the episode: Prasad's multifaceted background spanning agricultural sciences to pharmaceuticals. Eyegenex's pioneering work in gene and peptide therapies for ophthalmic conditions. The…
  continue reading
 
DJ Nick Luscombe, OIST Podcaster in Residence, checks out OIST's Visiting Program (TSVP). In this episode, he introduces the Thematic Programs that started last year as part of the TSVP. He talks to Dr. Samuel Ross, OIST researcher who is the scientific coordinator for the second the Thematic Program on "The Future of Response Diversity and Ecosyst…
  continue reading
 
Embark on a journey into the future of healthcare with the fifth OIST podcast episode on the Global Bioconvergence Center of Innovation. DJ Nick Luscombe dives deep into groundbreaking research with Profs. Amy Shen and Keiko Kono, who are reshaping healthcare through microfluidic devices and anti-senescence supplements. From disease detection to fo…
  continue reading
 
In the latest episode of OIST’s Global Bioconvergence Center podcast series, DJ Nick Luscombe speaks to the team managing the Global Bioconvergence Center of Innovation at the Okinawa Institute of Science and Technology (OIST) about the highlights and challenges of pursuing the new center’s long-term objectives. The core team ensures the smooth run…
  continue reading
 
This panel discussion on startup commercial strategy explores key elements and insights from industry leaders, Paul Bresge, Aziz Mottiwala, Todd Pinkney, Cari Stone and Adam Szaronos, offering a comprehensive view of the journey from regulatory approval to commercialization. Beth Marsh, Lead of Sales and Marketing at Apellis, sets the stage by emph…
  continue reading
 
OIS Podcast host Carey Powers speaks with Dr. Adrienne Graves and Dr. Barbara Wirostko on 'Maximizing the Value of Your Board of Director' live from OIS XIII. Dr. Graves and Dr. Wirostko share valuable insights on: * Building effective boards * Significance of diversity * CEO and board member communications * Navigating decision-making * Board dyna…
  continue reading
 
In this episode of the OIST Podcast, we introduce listeners to the latest episode of New Ratio, a podcast by OIST Podcaster in Residence DJ Nick Luscombe. In this interview and performance recorded at OIST in August of 2023, Okinawan musician ARAGAKI Mutsumi demonstrates how she combines Okinawan sanshin and traditional singing with environmental r…
  continue reading
 
In this episode of the OIS Podcast, host Dr. Firas Rahhal, along with expert panelists, Dr. Robert Bhisitkul, Dr. Alan Franklin and Dr. Paul Karpecki at OIS XIII, takes listeners on a deep dive into the transformative landscape of oral therapies in retina treatment, challenging the conventional approach dominated by eye injections. Tune in as they …
  continue reading
 
ViaLase, a clinical stage medical technology company located in Aliso Viejo, CA is focused on disrupting the conventional glaucoma treatment paradigm with the introduction of a truly noninvasive image-guided femtosecond laser treatment that enhances glaucoma patient care. With a leadership team that has vast experience developing, designing, manufa…
  continue reading
 
In the latest episode of our Global Bioconvergence Center of Innovation podcast series, DJ Nick Luscombe speaks with researchers from the OKEON Churamori Project, who use genomics, machine learning and acoustic monitoring to gain new insights into ecosystem health. Get more information at the Global Bioconvergence Center of Innovation.…
  continue reading
 
In this second episode of the Global Bioconvergence Center of Innovation podcast series, DJ Nick Luscombe discusses coral reef research at OIST with Prof. Nori Satoh and Prof. Timothy Ravasi. From field trips to exotic places, to the valuable support of local Okinawans, it’s a fascinating journey!
  continue reading
 
Opthea, an Australian based biopharmaceutical company is dedicated to transforming retinal disease treatments and elevating patients' vision and quality of life. Join Firas Rahal, MD, in a captivating episode as he engages with Opthea's Founder and Chief Innovation Officer, Megan Baldwin, PhD. Explore the compelling journey from oncology to ophthal…
  continue reading
 
Harrow isn’t a household name (yet), but eye care professionals have trusted its products for over a decade. The Nashville-based company produces Dexycu, an intraocular steroid; Iopidine for intraocular pressure control; and most recently, five Novartis products that Harrow acquired in December 2022. Rob Rothman, MD, caught up with Harrow founder a…
  continue reading
 
Endogena Therapeutics has developed a novel approach to regenerative medicine that’s not only scientifically compelling, but practical. Endogena’s technology unlocks the body’s own stem cells for controlled tissue repair by small molecules. Its products use a dosing schedule that could move easily into the system already in place for intravitreal i…
  continue reading
 
Delve into the first episode of a six-part series on the innovative research conducted at the Global Bioconvergence Center of Innovation. DJ Nick Luscombe, OIST Podcaster in Residence, talks to Prof. Tom Froese, leader of the Embodied Cognitive Science Unit at OIST. They discuss the center’s research on mental health and what mental well-being mean…
  continue reading
 
“You can see and feel a buzz within the company right now,” said Andrew Stewart, President, Global Pharmaceuticals and International Consumer, at Bausch + Lomb. Bausch + Lomb’s current momentum stems not only from new leadership, but also from recent collaborations, partnerships, and acquisitions. Stewart and Yehia Hashad, MD, Executive Vice Presid…
  continue reading
 
OIS Podcast host Carey Powers caught up with four ophthalmology execs and one principal investigator to talk about some of the most exciting developments in retina R&D. Her guests include: Houman David Hemmati, MD, PhD, Cofounder and Chief Medical Officer of Optigo Biotherapeutics Michael Tsipursky, MD, CEO and Cofounder of Revive Biotech Michael S…
  continue reading
 
OIS Podcast host Carey Powers speaks with four CEOs from leading retina-focus companies to talk about all things innovation. Her guests include: • Kerrie Brady, BPharm, President and CEO of OcuTerra • Rich Small, CEO of NeuroTech Pharmaceuticals • Kester Nahen, PhD, CEO of Notal Vision • Brad Doerschuk, President and CEO of InFocus Clinical OcuTerr…
  continue reading
 
DJ Nick Luscombe, OIST Podcaster in Residence, checks out OIST's Theoretical Sciences Visiting Program (TSVP). In this episode, he talks to Dr. Jonas Fischer, TSVP Academic Coordinator, and Prof. Simone Pigolotti to learn more about the program. He also interviews the guest researchers visiting OIST as part of the program and asks them about their …
  continue reading
 
At-home OCT enables daily monitoring of patients with neovasular age-related macular degeneration (AMD) and other patients that need a lot of follow-ups. With host Carey Powers, Dr. Anat Loewenstein dives into at-home OCT innovation, application, and adoption. Dr. Loewenstein is Head of the Department of Ophthalmology and Vice Dean at Tel Aviv Medi…
  continue reading
 
Keith Valentine is the first and only visually impaired head of a national sight loss organization in the UK. As the President and CEO of Vision Foundation, London’s leading sight loss charity, Valentine guides an organization that provides services for blind and visually impaired people countrywide. He also has plans to increase the organization’s…
  continue reading
 
Two recent drug approvals changed the game for ocular surface disease: Xdemvy (lotilaner ophthalmic solution) 0.25 percent (Tarsus Pharmaceuticals) for Demodex blepharitis, and Miebo (perfluorohexyloctane ophthalmic solution) from Bausch + Lomb and Novaliq for evaporative dry eye disease. On today’s podcast, two ocular surface disease experts talk …
  continue reading
 
Yari Mitchell spent nearly 13 years with AcuFocus, an ophthalmic device company, before overseeing its acquisition by Bausch + Lomb. As head of Y Factor Consulting, she now helps innovators move their product from the lab to a funded company. Greg Kunst, President and CEO of Aurion Biotech, a cell therapy company, led the start-up to a $120 million…
  continue reading
 
Wesley Jackson, PhD, spent years conducting post-doctoral research and writing grants, all the while setting the wheels in motion to launch Valitor. Valitor is developing VLTR-557 a long-lasting anti-VEGF. The technology platform, a multivalent polymer (MVP), is integral to VLTR-557. With Firas Rahhal, MD, Dr. Jackson shares why he stuck with the s…
  continue reading
 
Loading …

クイックリファレンスガイド